Bank of New York Mellon’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-73
Closed -$1.89K 4165
2024
Q4
$1.89K Hold
73
﹤0.01% 4116
2024
Q3
$2.95K Hold
73
﹤0.01% 4090
2024
Q2
$2.69K Hold
73
﹤0.01% 4118
2024
Q1
$5.39K Hold
73
﹤0.01% 4138
2023
Q4
$6.47K Hold
73
﹤0.01% 4284
2023
Q3
$6.91K Hold
73
﹤0.01% 4317
2023
Q2
$13.1K Hold
73
﹤0.01% 4326
2023
Q1
$19.2K Hold
73
﹤0.01% 4313
2022
Q4
$11.3K Hold
73
﹤0.01% 4414
2022
Q3
$16K Hold
73
﹤0.01% 4474
2022
Q2
$35K Hold
73
﹤0.01% 4423
2022
Q1
$33K Buy
+73
New +$37.2K ﹤0.01% 4578

Other funds holding EDVA

Bank of New York Mellon's EDVA Position: Q1 2025 in Review

Bank of New York Mellon sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 73 shares — an estimated $1.89K sold.

Bank of New York Mellon first reported a position in EDVA in Q1 2022 and held it in 12 quarters. The position peaked at $35K in Q2 2022. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

  • Bank of New York Mellon reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 73 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $1.89K.
  • Bank of New York Mellon first reported a position in Endovia Health Sciences, Inc. in Q1 2022 and held it in 12 quarters.
  • Bank of New York Mellon's Endovia Health Sciences, Inc. position peaked at $35K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.